RESUMO
recA protein forms stable filaments on duplex DNA at low pH. When the pH is shifted above 6.8, recA protein remains stably bound to nicked circular DNA, but not to linear DNA. Dissociation of recA protein from linear duplex DNA proceeds to a non-zero endpoint. The kinetics and final extent of dissociation vary with several experimental parameters. The instability on linear DNA is most readily explained by a progressive unidirectional dissociation of recA protein from one end of the filament. Dissociation of recA protein from random points in the filament is eliminated as a possible mechanism by several observations: (1) the requirement for a free end; (2) the inverse and linear dependence of the rate of dissociation on DNA length (at constant DNA base-pair concentration); and (3) the kinetics of exposure of a restriction endonuclease site in the middle of the DNA. Evidence against another possible mechanism, ATP-mediated translocation of the filament along the DNA, is provided by a novel effect of the non-hydrolyzable ATP analog, ATP gamma S, which generally induces recA protein to bind any DNA tightly and completely inhibits ATP hydrolysis. We find that very low, sub-saturating levels of ATP gamma S completely stabilize the filament, while most of the ATP hydrolysis continues. If these levels of ATP gamma S are introduced after dissociation has commenced, further dissociation is blocked, but re-association does not occur. These observations are inconsistent with movement of recA protein along DNA that is tightly coupled to ATP hydrolysis. The recA nucleoprotein filament is polar and the protein binds the two strands asymmetrically, polymerizing mainly in the 5' to 3' direction on the initiating strand of a single-stranded DNA tailed duplex molecule. A model consistent with these results is presented.
Assuntos
DNA Bacteriano/metabolismo , Nucleoproteínas/metabolismo , Recombinases Rec A/metabolismo , Trifosfato de Adenosina/metabolismo , Enzimas de Restrição do DNA/metabolismo , DNA de Cadeia Simples/metabolismo , DNA Super-Helicoidal/metabolismo , Desoxirribonucleases/metabolismo , Concentração de Íons de Hidrogênio , HidróliseAssuntos
2-Acetilaminofluoreno/farmacologia , Carcinógenos/farmacologia , Dano ao DNA , Mutação da Fase de Leitura , Mutagênese , Conformação de Ácido Nucleico , Composição de Bases , Sequência de Bases , DNA/química , DNA/efeitos dos fármacos , DNA Bacteriano/química , DNA Bacteriano/efeitos dos fármacos , Escherichia coli/efeitos dos fármacos , Escherichia coli/genética , Desnaturação de Ácido Nucleico , Ácidos Nucleicos Heteroduplexes , Deleção de SequênciaAssuntos
Adenosina Trifosfatases/metabolismo , DNA Topoisomerases Tipo II/análise , DNA Topoisomerases Tipo II/metabolismo , Adenosina Trifosfatases/análise , Trifosfato de Adenosina/metabolismo , Soluções Tampão , Cinética , L-Lactato Desidrogenase/metabolismo , NAD/metabolismo , Fosfoenolpiruvato/metabolismo , Piruvato Quinase/metabolismo , Saccharomyces cerevisiae/enzimologia , Espectrofotometria/métodosAssuntos
Celulose/análogos & derivados , DNA Topoisomerases Tipo II/isolamento & purificação , DNA Topoisomerases Tipo II/metabolismo , Plasmídeos , Saccharomyces cerevisiae/enzimologia , Celulose/química , DNA Topoisomerases Tipo II/genética , Ácidos Nucleicos/metabolismo , Polietilenoimina/química , Saccharomyces cerevisiae/genéticaRESUMO
A covalently cross-linked dimer of yeast DNA topoisomerase II was created by fusing the enzyme with the GCN4 leucine zipper followed by two glycines and a cysteine. Upon oxidation of the chimeric protein, a disulfide bond forms between the two carboxyl termini, covalently and intradimerically cross-linking the two protomers. In addition, all nine of the cysteines naturally occurring in topoisomerase II have been changed to alanines in this construct. This cross-linked, cysteine-less topoisomerase II is catalytically active in DNA duplex passage as indicated by ATP-dependent DNA supercoil relaxation and kinetoplast DNA decatenation assays. However, these experiments do not directly distinguish between a "one-gate" and a "two-gate" mechanism for the enzyme.
Assuntos
DNA Topoisomerases Tipo II/metabolismo , DNA de Cinetoplasto/metabolismo , Saccharomyces cerevisiae/enzimologia , Adenosina Trifosfatases/metabolismo , Trifosfato de Adenosina/metabolismo , Sequência de Aminoácidos , Animais , Catálise , Crithidia fasciculata , DNA Topoisomerases Tipo II/biossíntese , DNA Topoisomerases Tipo II/química , DNA de Cinetoplasto/análise , DNA de Cinetoplasto/química , DNA Super-Helicoidal/metabolismo , Substâncias Macromoleculares , Modelos Estruturais , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Conformação de Ácido Nucleico , Conformação Proteica , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismoRESUMO
A cloned yeast TOP2 gene was modified to produce yeast DNA topoisomerase II (EC 5.99.1.3) epitopically labeled at its amino or carboxyl terminus. Limited digestion with SV8 endoprotease shows three distinct protease-sensitive sites in each polypeptide of the dimeric enzyme. These sites were mapped by immunostaining of the end-labeled proteolytic fragments resolved by SDS/polyacrylamide gel electrophoresis; two of the mapped locations were confirmed by sequencing the amino ends of two unlabeled peptic fragments. Proteolytic cleavage by SV8 endoprotease at a pair of sites corresponding to the carboxyl sides of Glu-411 and Glu-680 is modulated by the binding of the nonhydrolyzable ATP analogs adenosine 5'-[beta, gamma-imido]triphosphate (5'-adenylyl imidodiphosphate) and adenosine 5'-[gamma-thio]triphosphate: in their absence cleavage occurs predominantly at Glu-411; in the presence of either analog, cleavage occurs predominantly at Glu-680. These results are interpreted in terms of allosteric interdomainal movements in the type II DNA topoisomerase following the binding of ATP.
Assuntos
Trifosfato de Adenosina/metabolismo , DNA Topoisomerases Tipo II/metabolismo , Saccharomyces cerevisiae/enzimologia , Regulação Alostérica , Sequência de Aminoácidos , Sítios de Ligação , Clonagem Molecular , DNA Topoisomerases Tipo II/genética , DNA Topoisomerases Tipo II/imunologia , Endopeptidases , Epitopos/análise , Substâncias Macromoleculares , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Fragmentos de Peptídeos/isolamento & purificação , Saccharomyces cerevisiae/genéticaRESUMO
The mechanism by which T7 DNA polymerase (exo-) bypasses N-2-acetylaminofluorene (AAF) and N-2-aminofluorene (AF) adducts was studied by single-turnover kinetics. These adducts are known to be mutagenic in several cell types, and their bypass was studied in the framework of understanding how they promote mutations. Synthetic primer/templates were made from a template sequence containing a single guanine, to which the adducts were covalently attached, and one of three primers whose 3' ends were various distances from the adduct in the annealed substrates. Upon approaching the site of either adduct, the polymerase was found to add nucleotides as rapidly as to unmodified primer/templates, until just opposite the lesion. The incorporation rate of dCTP (at 100 microM) opposite AF-dG or AAF-dG was approximately 5 x 10(4)- and 4 x 10(6)-fold slower, respectively, than incorporation at the same position into an unmodified primer/template. The polymerase dissociated from the sites of the adducts at approximately the same rate that it dissociated from unmodified DNA. Correct nucleotide incorporation was favored both opposite and immediately after AF-dG. However, at both positions, dATP was the most rapidly misincorporated nucleotide. Misincorporation of dATP was more rapid than correct nucleotide incorporation both opposite and immediately after AAF-dG. These results are discussed in terms of the effects of AF and AAF adducts in vivo.
Assuntos
2-Acetilaminofluoreno/farmacologia , Bacteriófago T7/enzimologia , Replicação do DNA/efeitos dos fármacos , DNA Polimerase Dirigida por DNA/metabolismo , Fluorenos/farmacologia , Mutagênicos/farmacologia , Sequência de Bases , Dano ao DNA , Primers do DNA/metabolismo , Cinética , Modelos Genéticos , Dados de Sequência Molecular , Mutagênese , Nucleotídeos/metabolismo , Proteínas Recombinantes/metabolismoRESUMO
Type II DNA topoisomerases function as homodimeric enzymes in transiently cleaving double-stranded DNA to catalyze unlinking and unknotting reactions. The dimeric enzyme creates a DNA double-strand break by forming a covalent attachment between an active site tyrosine from each monomer and a 5'-phosphate from each strand of DNA. The dimer must be very stable to dissociation or subunit exchange when covalently attached to DNA to prevent directly or indirectly catalyzed rearrangements of the genome. Past studies have indicated conflicting results for the monomer-dimer stability of topoisomerase II in solution. Here, we report results from sedimentation equilibrium studies and two different subunit exchange assays indicating that purified Saccharomyces cerevisiae DNA topoisomerase II exists as a stable dimer in solution, with a Kd estimated to be < or = 10(-11) M. This high dimer stability is not detectably altered by a change of ionic strength or by the presence of ATP, ADP, or DNA.
Assuntos
DNA Topoisomerases Tipo II/química , Difosfato de Adenosina/farmacologia , Trifosfato de Adenosina/farmacologia , Centrifugação com Gradiente de Concentração , Centrifugação Isopícnica , DNA/farmacologia , DNA Topoisomerases Tipo II/efeitos dos fármacos , DNA Topoisomerases Tipo II/metabolismo , Dimerização , Estabilidade Enzimática , Modelos Moleculares , Concentração Osmolar , Conformação Proteica , Saccharomyces cerevisiae/enzimologiaRESUMO
RecA protein primarily associates with and dissociates from opposite ends of nucleoprotein filaments formed on linear duplex DNA. RecA nucleoprotein filaments that are hydrolyzing ATP therefore engage in a dynamic process under some conditions that has some of the properties of treadmilling. We have also investigated whether the net polymerization of recA protein at one end of the filament and/or a net depolymerization at the other end drives unidirectional strand exchange. There is no demonstrable correlation between recA protein association/dissociation and the strand exchange reaction. RecA protein-mediated DNA strand exchange is affected minimally by changes in reaction conditions (dilution, pH shift, or addition of small amounts of adenosine-5'-O-(3-thiotriphosphate) that have large and demonstrable effects on recA protein association, dissociation, or both. Rather than driving strand exchange, these assembly and disassembly processes may simply represent the mechanism by which recA nucleoprotein filaments are recycled in the cell.
Assuntos
DNA/metabolismo , Recombinases Rec A/metabolismo , Trifosfato de Adenosina/análogos & derivados , Trifosfato de Adenosina/metabolismo , Trifosfato de Adenosina/farmacologia , DNA Bacteriano/metabolismo , DNA Circular/metabolismo , DNA de Cadeia Simples/metabolismo , DNA Super-Helicoidal/metabolismo , DNA Viral/metabolismo , Escherichia coli/genética , Concentração de Íons de Hidrogênio , Hidrólise , Cinética , Nucleoproteínas/metabolismo , PolímerosRESUMO
The recA protein from Escherichia coli can homologously align two duplex DNA molecules; however, this interaction is much less efficient than the alignment of a single strand and a duplex. Three strand paranemic joints are readily detected. In contrast, duplex-duplex pairing is detected only when the incoming (second) duplex is negatively supercoiled, and even here the pairing is inefficient. The recA protein-promoted four strand exchange reaction is initiated in a three strand region, with efficiency increasing with the length of potential three strand pairing available for initiation. This indicates that a paranemic joint involving three DNA strands may be an important intermediate in all recA protein-mediated DNA strand exchange reactions and that the presence of three strands rather than four is a fundamental structural parameter of paranemic joints.
Assuntos
DNA Viral/metabolismo , Recombinases Rec A/metabolismo , Composição de Bases , Colífagos/metabolismo , DNA de Cadeia Simples/metabolismo , Escherichia coli/metabolismo , Ligação de Hidrogênio , Cinética , Modelos Moleculares , Modelos Estruturais , Conformação de Ácido Nucleico , Mapeamento por Restrição , Especificidade por SubstratoRESUMO
The initial rates of ATP hydrolysis and relaxation of negatively supercoiled DNA by highly purified wild-type and mutant yeast DNA topoisomerase II were measured under identical conditions to study the coupling between the ATPase activity of a type II DNA topoisomerase and its catalysis of the transport of one DNA segment through another. The results indicate that the binding of the enzyme to DNA stimulates its intrinsic ATPase activity by about 20-fold, and ATP binding to the pair of ATPase sites in a DNA-bound dimeric enzyme appears to be cooperative. The cooperativity in ATP binding may be significant in the coordination of the two halves of a DNA-bound enzyme dimer. At low ATP concentrations, the rate-limiting step in ATP usage appears to be slower than that in DNA transport, and DNA transport is relatively efficient in terms of ATP consumption: 1.9 +/- 0.5 ATP molecules are hydrolyzed/DNA transport event. At a saturating ATP concentration, however, there appears to be a reversal of these rate-limiting steps, and DNA transport is less efficient: 7.4 +/- 1.0 ATP molecules are hydrolyzed/DNA transport event. These data are interpreted in terms of a model in which a DNA-bound enzyme acts as an ATP-operated clamp for the capture and transport of a second DNA segment.
Assuntos
Adenosina Trifosfatases/metabolismo , Trifosfato de Adenosina/metabolismo , DNA Topoisomerases Tipo II/metabolismo , DNA Super-Helicoidal/metabolismo , Saccharomyces cerevisiae/enzimologia , Difosfato de Adenosina/farmacologia , Adenosina Trifosfatases/genética , Adenosina Trifosfatases/isolamento & purificação , Trifosfato de Adenosina/farmacologia , Adenilil Imidodifosfato/farmacologia , Sequência de Aminoácidos , Sequência de Bases , DNA Topoisomerases Tipo II/genética , DNA Topoisomerases Tipo II/isolamento & purificação , DNA Fúngico/genética , DNA Fúngico/metabolismo , Cinética , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Oligodesoxirribonucleotídeos , Proteínas Recombinantes/isolamento & purificação , Proteínas Recombinantes/metabolismo , Saccharomyces cerevisiae/genéticaRESUMO
When bound to DNA, topoisomerase II from Saccharomyces cerevisiae exhibits burst kinetics with respect to ATP hydrolysis. Pre-steady-state analysis shows that the enzyme binds and hydrolyzes two ATP per reaction cycle. Our data indicate that at least one of the two ATP is rapidly hydrolyzed prior to the rate-determining step in the reaction mechanism. When DNA is not bound to topoisomerase II, the rate-determining step shifts to become either ATP binding or hydrolysis. Two possible mechanisms are proposed that agree with our observations.
Assuntos
Trifosfato de Adenosina/metabolismo , DNA Topoisomerases Tipo II/metabolismo , DNA/metabolismo , Saccharomyces cerevisiae/enzimologia , Animais , Sítios de Ligação , DNA Topoisomerases Tipo II/química , Diálise , Hidrólise , Cinética , Modelos Químicos , Ligação Proteica , Salmão , Contagem de Cintilação , Fatores de TempoRESUMO
Ligand-induced allosteric changes in proteins are important in their cellular functions and regulation, and both concerted and sequential examples are known. The distinction has entailed elaborate analysis, however, and only a few systems have been unequivocally analysed. We have investigated the coupling between ATP usage and DNA transport by type II DNA topoisomerases, and one key question concerning allostery in these dyadic enzymes is whether ATP binding to one protomer can induce a concerted conformational change in the entire enzyme. Here we use an enzyme with one immunotagged subunit defective in ATP binding and one wild-type subunit to show that it can. Our approach should be generally applicable in the study of allostery and communication between members of a macromolecular assembly.
Assuntos
Trifosfato de Adenosina/metabolismo , DNA Topoisomerases Tipo II/metabolismo , DNA Fúngico/metabolismo , Conformação Proteica , Adenilil Imidodifosfato/farmacologia , Regulação Alostérica , Sequência de Aminoácidos , DNA Topoisomerases Tipo II/química , DNA Topoisomerases Tipo II/genética , Epitopos/análise , Ligantes , Substâncias Macromoleculares , Mutagênese Sítio-Dirigida , Fragmentos de Peptídeos/isolamento & purificação , Conformação Proteica/efeitos dos fármacos , Proteínas Recombinantes/química , Proteínas Recombinantes/isolamento & purificação , Proteínas Recombinantes/metabolismo , Saccharomyces cerevisiae/enzimologia , Saccharomyces cerevisiae/genéticaRESUMO
Topoisomerase II-catalyzed DNA transport requires coordination between two distinct reactions: ATP hydrolysis and DNA cleavage/religation. To further understand how these reactions are coupled, inhibition by the clinically used anticancer drug etoposide was studied. The IC(50) for perturbing the DNA cleavage/religation equilibrium is nucleotide-dependent; its value is 6 microM in the presence of ATP, 25 microM in the presence of a nonhydrolyzable ATP analog, and 45 microM in the presence of ADP or no nucleotide. This inhibition was further characterized using steady-state and pre-steady-state ATPase and decatenation assays. Etoposide is a hyperbolic noncompetitive inhibitor of the ATPase activity with a K(i)(app) of 5.6 microM no inhibition of ATP hydrolysis is seen in the absence of DNA cleavage. In order to determine which steps of the ATPase mechanism etoposide inhibits, pre-steady-state analysis was performed. These results showed that etoposide does not reduce the rate of binding two ATP, hydrolyzing the first ATP, or releasing the second ADP. Inhibition is therefore associated with the first product release step or hydrolysis of the second ATP, suggesting that DNA religation normally occurs at one of these two steps. Multiple turnover decatenation is inhibited when etoposide is present; however, single turnover decatenation occurs normally. The implications of these results are discussed in terms of their contribution to our current model for the topoisomerase II mechanism.
Assuntos
Difosfato de Adenosina/metabolismo , Trifosfato de Adenosina/metabolismo , DNA Topoisomerases Tipo II/metabolismo , Etoposídeo/farmacologia , Saccharomyces cerevisiae/enzimologia , Substituição de Aminoácidos , Hidrólise , Cinética , Modelos Químicos , Mutagênese Sítio-Dirigida , Plasmídeos , Proteínas Recombinantes/antagonistas & inibidores , Proteínas Recombinantes/metabolismo , Inibidores da Topoisomerase IIRESUMO
DNA topoisomerase II uses a complex, sequential mechanism of ATP hydrolysis to catalyze the transport of one DNA duplex through a transient break in another. ICRF-193 is a catalytic inhibitor of topoisomerase II that is known to trap a closed-clamp intermediate form of the enzyme. Using steady-state and rapid kinetic ATPase and DNA transport assays, we have analyzed how trapping this intermediate by the drug perturbs the topoisomerase II mechanism. The drug has no effect on the rate of the first turnover of decatenation but potently inhibits subsequent turnovers with an IC(50) of 6.5 +/- 1 microM for the Saccharomyces cerevisiae enzyme. This drug inhibits the ATPase activity of topoisomerase II by an unusual, mixed-type mechanism; the drug is not a competitive inhibitor of ATP, and even at saturating concentrations of drug, the enzyme continues to hydrolyze ATP, albeit at a reduced rate. Topoisomerase II that was specifically isolated in the drug-bound, closed-clamp form continues to hydrolyze ATP, indicating that the enzyme clamp does not need to re-open to bind and hydrolyze ATP. When rapid-quench ATPase assays were initiated by the addition of ATP, the drug had no effect on the sequential hydrolysis of either the first or second ATP. By contrast, when the drug was prebound, the enzyme hydrolyzed one labeled ATP at the uninhibited rate but did not hydrolyze a second ATP. These results are interpreted in terms of the catalytic mechanism for topoisomerase II and suggest that ICRF-193 interacts with the enzyme bound to one ADP.
Assuntos
DNA Topoisomerases Tipo II/metabolismo , Inibidores Enzimáticos/farmacologia , Piperazinas/farmacologia , Adenosina Trifosfatases/antagonistas & inibidores , Trifosfato de Adenosina/metabolismo , Dicetopiperazinas , Hidrólise , Cinética , Modelos Químicos , Saccharomyces cerevisiae/enzimologiaRESUMO
In the preceding paper, we showed that DNA topoisomerase II from Saccharomyces cerevisiae binds two ATP and rapidly hydrolyzes at least one of them before encountering a slow step in the reaction mechanism. These data are potentially consistent with two different types of reaction pathways: (1) sequential ATP hydrolysis or (2) simultaneous hydrolysis of both ATP. Here, we present results that are consistent only with topoisomerase II hydrolyzing its two bound ATP sequentially. Additionally, these results indicate that the products of the first hydrolysis are released from the enzyme before the second ATP is hydrolyzed. Release of products from both the first and second hydrolyses contributes to the rate-determining process. The proposed mechanism for ATP hydrolysis by topoisomerase II is complex, having nine rate constants. To calculate values for each of these rate constants, a technique of kinetic parameter estimation was developed. This technique involved using singular perturbation theory in order to estimate rate constants, and consequently identify kinetic steps following the rate-determining step.
Assuntos
Trifosfato de Adenosina/metabolismo , DNA Topoisomerases Tipo II/metabolismo , Saccharomyces cerevisiae/enzimologia , Difosfato de Adenosina/metabolismo , Trifosfato de Adenosina/química , Animais , Sítios de Ligação , DNA Topoisomerases Tipo II/química , Concentração de Íons de Hidrogênio , Hidrólise , Cinética , Modelos Químicos , Fosfatos/metabolismo , Coelhos , Salmão , Fatores de TempoRESUMO
DNA topoisomerase II catalyzes two different chemical reactions as part of its DNA transport cycle: ATP hydrolysis and DNA breakage/religation. The coordination between these reactions was studied using mutants of yeast topoisomerase II that are unable to covalently cleave DNA. In the absence of DNA, the ATPase activities of these mutant enzymes are identical to the wild type activity. DNA binding stimulates the ATPase activity of the mutant enzymes, but with steady-state parameters different from those of the wild type enzyme. These differences were examined through DNA binding experiments and pre-steady-state ATPase assays. One mutant protein, Y782F, binds DNA with the same affinity as wild type protein. This mutant topologically traps one DNA circle in the presence of a nonhydrolyzable ATP analog under the same conditions that the wild type protein catenates two circles. Rapid chemical quench and pulse-chase ATPase experiments reveal that the mutant proteins bound to DNA have the same sequential hydrolysis reaction cycle as the wild type enzyme. Binding of ATP to the mutants is not notably impaired, but hydrolysis of the first ATP is slower than for the wild type enzyme. Models to explain these results in the context of the entire DNA topoisomerase II reaction cycle are discussed.
Assuntos
DNA Topoisomerases Tipo II/metabolismo , DNA/metabolismo , Adenosina Trifosfatases/metabolismo , Sequência de Bases , Primers do DNA , DNA Topoisomerases Tipo II/química , Hidrólise , Cinética , TermodinâmicaRESUMO
DNA topoisomerase II is a homodimeric molecular machine that couples ATP usage to the transport of one DNA segment through a transient break in another segment. In the presence of a nonhydrolyzable ATP analog, the enzyme is known to promote a single turnover of DNA transport. Current models for the enzyme's mechanism based on this result have hydrolysis of two ATPs as the last step, used only to reset the enzyme for another round of reaction. Using rapid-quench techniques, topoisomerase II recently was shown to hydrolyze its two bound ATPs in a strictly sequential manner. This result is incongruous with the models based on the nonhydrolyzable ATP analog data. Here we present evidence that hydrolysis of one ATP by topoisomerase II precedes, and accelerates, DNA transport. These results indicate that important features of this enzyme's mechanism previously have been overlooked because of the reliance on nonhydrolyzable analogs for studying a single reaction turnover. A model for the mechanism of topoisomerase II is presented to show how hydrolysis of one ATP could drive DNA transport.
Assuntos
Trifosfato de Adenosina/metabolismo , DNA Topoisomerases Tipo II/metabolismo , DNA/metabolismo , Saccharomyces cerevisiae/enzimologia , Transporte Biológico , HidróliseRESUMO
DNA topoisomerase II catalyzes the transport of one DNA duplex through a transient break in a second duplex using a complex ATP hydrolysis mechanism. Two key rates in the ATPase mechanism, ATP resynthesis and phosphate release, were investigated using 18O exchange and stopped-flow phosphate release experiments, respectively. The 18O exchange results showed that the rate of ATP resynthesis on the topoisomerase II active site was slow compared with the rate of phosphate release. When topoisomerase II was bound to DNA, phosphate was released slowly, with a lag. Since each of the preceding steps is known to occur rapidly, phosphate release is apparently a rate-determining step. The length of the lag phase was unaffected by etoposide, indicating that inhibiting DNA religation inhibits the ATPase reaction cycle at some step following phosphate release. By combining the 18O exchange and phosphate release results, the rate constant for ATP resynthesis can be calculated as approximately 0.5 s(-1). These data support the mechanism of sequential hydrolysis of two ATP by DNA topoisomerase II.